Evidence map›Paper›PMID 34289265›Full record

ArticleAnnals of clinical and translational neurology2021

JKAP relates to disease risk, severity, and Th1 and Th17 differentiation in Parkinson's disease.

Qingwei Yang, Jingcong Zhuang, Pingping Cai, Longling Li, Rong Wang, Zhongjie Chen

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Differentiation and regulation of CD4Cellular and molecular life sciences : CMLS · 2024
    Review
  8. Observational
  9. Article
  10. Circulating JKAP levels may correlate with postpartum anxiety and depression through its interaction with T helper 17 cells.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Clinical value of serum JKAP in acute ischemic stroke patients.Journal of clinical laboratory analysis · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qingwei YangDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Jingcong ZhuangDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.ORCID 0000-0001-6856-9090
Pingping CaiDepartment of Neurology, Fujian Medical University Xiamen Humanity Hospital, Xiamen, China.
Longling LiDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Rong WangDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Zhongjie ChenDepartment of Neurology, Zhongshan Hospital Xiamen University, Xiamen, China.
Xiamen University · CNFujian Medical University · CN

Funding

Medical Elite Cultivation Program of Fujian, China 2018-ZQN-85
6 · The paper itself

Abstract

objectiveJNK pathway-associated phosphatase (JKAP) is previously reported to regulate immune/inflammatory process via T-cell signaling, and closely involves in neurological diseases, while its implication in Parkinson's disease (PD) is unknown. Therefore, this study aimed to investigate the correlation of JKAP with Th1/Th2/Th17 cells and their clinical roles in PD patients, and then further explore the effect of JKAP on regulating CD4

methodsTotally 50 PD patients and 50 age-/gender-matched controls were enrolled. Their blood samples were collected and proposed to ELISA and flow cytometry assays for JKAP, Th1, Th2, and Th17 measurements. In vitro, CD4

resultsJKAP was downregulated in PD patients compared to controls, which also showed good potency to discriminate them. Besides, JKAP negatively correlated with Th1 and Th17 cell proportions, but did not associate with Th2 cell proportion in PD patients; Interestingly, JKAP did not correlated with Th1, Th2, or Th17 cell proportions in controls. Furthermore, JKAP correlated with some parts of unified Parkinson's Disease Rating Scale (UPDRS) and Mini-Mental State Examination (MMSE) score. In vitro, JKAP overexpression repressed CD4

interpretationJKAP associates with disease risk and severity, correlates with Th1 and Th17 cells, and regulates CD4

Indexed as

Th17 CellsTh1 CellsAgedCD4-Positive T-LymphocytesCell DifferentiationDown-RegulationDual-Specificity PhosphatasesFemaleHumansLymphocyte ActivationMaleMiddle AgedMitogen-Activated Protein Kinase PhosphatasesParkinson DiseasePatient AcuityRiskDual-Specificity PhosphatasesDUSP22 protein, humanMitogen-Activated Protein Kinase Phosphatases

Identifiers

PMID34289265
PMCPMC8419400
OpenAlexW3186904229

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.